Sherman F. Stinson

Reata Pharmaceuticals (United States) — United States

Medicine · Health Sciences

29h-index2.7kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(7), HIV/AIDS drug development and treatment(6), Cancer therapeutics and mechanisms(6), HIV Research and Treatment(5), Carcinogens and Genotoxicity Assessment(5)

Publications69 total

Optimization of Naphthalimide-imidazoacridone with Potent Antitumor Activity Leading to Clinical Candidate (HKH40A, RTA 502)
Journal of Medicinal Chemistry·2007· 25 cited
Design, Synthesis, and Evaluation of In Vivo Potency and Selectivity of Epoxysuccinyl-Based Inhibitors of Papain-Family Cysteine Proteases
Chemistry & Biology·2007· 67 cited
Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl
Cancer Chemotherapy and Pharmacology·2005· 11 cited
Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
Cancer Chemotherapy and Pharmacology·2005· 43 cited
The importance of the pharmacology of luciferin and its effect on bioluminescent endpoints when conducting in vivo and in vitro experiments
Cancer Research·2005
The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-??B activity in drug-sensitive MCF-7 cells
Anti-Cancer Drugs·2005· 33 cited
Synthesis, structure–activity relationship, and p210bcr-abl protein tyrosine kinase activity of novel AG 957 analogs
Bioorganic & Medicinal Chemistry·2005· 29 cited
FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS
Drug Metabolism and Disposition·2004· 53 cited
Poly(ethylene glycol) Prodrugs of the CDK Inhibitor, Alsterpaullone (NSC 705701):  Synthesis and Pharmacokinetic Studies
Bioconjugate Chemistry·2004· 17 cited
17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models
Anti-Cancer Drugs·2004· 88 cited
NCI Specialized Procedures in Preclinical Drug Evaluations
Humana Press eBooks·2004· 5 cited
Clinical Pharmacology of Flavopiridol following a 72-Hour Continuous Infusion
Annals of Pharmacotherapy·2003· 42 cited
SarCNU, a Nitrosourea Analog on a Day 1, 5, and 9 Oral Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Tumors
Journal of Clinical Oncology·2003· 5 cited
Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.
PubMed·2002· 76 cited
Identification of the major metabolite of 2,5-bis(5-hydroxymethyl-2-thienyl)furan (NSC 652287), an antitumor agent, in the S9 subcellular fraction of dog liver cells
Journal of Chromatography B·2002· 4 cited
Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse
Xenobiotica·2002· 24 cited
Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
PubMed·2000· 102 cited
Identification of the principal circulating metabolite of a synthetic 5,4′-diaminoflavone (NSC 686288), an antitumor agent, in the rat
Journal of Chromatography B Biomedical Sciences and Applications·2000· 2 cited
Antitumor Benzothiazoles. 8. Synthesis, Metabolic Formation, and Biological Properties of the <i>C</i>- and <i>N</i>-Oxidation Products of Antitumor 2-(4-Aminophenyl)benzothiazoles
Journal of Medicinal Chemistry·1999· 226 cited
Analysis of 2-(3-methyl-4-aminophenyl)-benzothiazole (NSC 674495) in plasma by gas chromatography with mass-selective detection
Journal of Chromatography B Biomedical Sciences and Applications·1999
page 1 of 4Next →

Frequent Co-authors

Edward A. Sausville(14), Gerd Reznik(8), Jerrold M. Ward(7), Tracey D. Bradshaw(4), Malcolm F. G. Stevens(4), Michael B. Sporn(4), Eileen Brantley(4), Adrian M. Senderowicz(3), Donna Headlee(3), Kimberly D. Hill(3), Robert Schultz(3), Clayton G. Loosli(3), John P. Bader(3), V. L. Narayanan(3), Umberto Saffiotti(3), Richard M. Lush(2), William D. Figg(2), Susan G. Arbuck(2), Francisco Arguello(2), Erik M. Smith(2)